Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Value-Based Care, Consumerism, Behavioral Health, and Social Determinants to Drive Clinical AI Adoption


News Image

…With a new surge in Covid-19 extending the toll on health systems through at least early 2022, clinical AI will be more essential than ever to prevent negative quality events and keep costs down.

Jvion, a leader in prescriptive clinical artificial intelligence (AI), today announced their predictions for healthcare in 2021. As the outcome of the 2020 election comes into focus and the pandemic surges to its most severe stage yet, both factors will weigh heavily on the direction of healthcare in the year to come.

“With the election decided, it’s clear that health system revenue will continue to shift to value-based care models,” said Dr. John Showalter, Jvion’s Chief Product Officer. “Once it reaches a tipping point of 50% of total revenue, providers’ financial performance will be inextricably linked to their patients’ outcomes.”

“To survive, providers and payers will need to harness their data to predict and mitigate patient risk, and prescriptive clinical AI will be an essential capability,” adds Dr. John Frownfelter, Jvion’s Chief Medical Information Officer. “And with a new surge in Covid-19 extending the toll on health systems through at least early 2022, clinical AI will be more essential than ever to prevent negative quality events and keep costs down.”

In this context, Dr. Frownfelter and Dr. Showalter predict four key trends will drive change in healthcare in 2021:

Value-based care accelerates, hinging on election and Supreme Court outcomes.

  • A Joe Biden presidency will likely accelerate the trend towards value-based care, with the pace depending on who ultimately controls the Senate following runoff races in Georgia. Democratic control will likely lead to a stronger legislative push for capitation over fee-for-service models, while divided government may limit action to the executive agency level. The Supreme Court will also impact this trend if the ACA’s value-based incentives are upheld or overruled.

Consumerism will drive greater transparency in clinical AI applications.

  • As patients shoulder an increasing burden of healthcare costs, and new HHS rules require greater price transparency, patients will be more engaged in their care and demand to know why costly procedures and services are necessary. This trend will drive healthcare payers to invest in prescriptive clinical AI platforms that deliver personalized care plans and engagement recommendations for their members. With more transparency around the use of clinical AI, patients will better understand their risk and be empowered to take action to reduce their risk.

Clinical AI adoption will expand for behavioral health use cases.

  • The pandemic has fueled a national mental health crisis, with 40.9% of Americans showing signs of adverse mental or behavioral health conditions. Combined with the shift to value-based reimbursement models, these trends will drive more behavioral health providers to adopt prescriptive clinical AI solutions to predict which patients are at risk and apply clinically-validated interventions to prevent adverse behavioral health outcomes.

Pandemic economy will intensify impact of social determinants on health outcomes.

  • 8 million Americans have been driven to poverty since the pandemic recession began. This means social determinants of health (SDOH), such as unemployment, housing instability and malnutrition, will have a greater impact on patient outcomes in 2021. To improve outcomes, providers will need to better understand the social and economic needs of individual patients, how they impact their risk, and what resources can be leveraged to address their needs. Prescriptive clinical AI will be a valuable tool for delivering these population health insights.

About Jvion:

Jvion, a leader in clinical artificial intelligence, enables providers, payers and other healthcare entities to identify and prevent avoidable patient harm, utilization and costs. An industry first, the Jvion CORE™ goes beyond predictive analytics and machine learning to identify patients on a trajectory to becoming high-risk. Jvion then determines the interventions that will more effectively reduce risk and enable clinical and operational action. The CORE accelerates time to value by leveraging established patient-level intelligence to drive engagement across healthcare organizations, populations, and individuals. To date, the Jvion CORE has been deployed across hundreds of clients and resulted in millions saved. For more information, visit https://www.jvion.com.

Jvion PR Contact:

Lexi Herosian

lexi@scratchmm.com

Share article on social media or email:

Bridge The Gap™ Podcast and #ActivitiesStrong Partner to Combat Isolation in Senior Living Communities


Due to COVID-19, social isolation has become the single biggest reason for the rapid decline of the cognitive and physical health of residents in senior living communities. Since March 2020, 80% of residents have not had a visit from the outside. Strained activity departments now need to hire an additional 1.2 FTE to deliver the same quality of engagement due to social distancing and isolation measures, with no additional hiring in sight due to slimming of margins most providers have experienced. The activity and life enrichment department is in charge of ensuring every resident can have access to their basic human right of finding purpose every day. Often underfunded and with little communication to executive leadership in their communities, this department has often been left aside and not respected.

The #ActivitiesStrong Initiative led by Linked Senior, is excited to partner with the Bridge The Gap™ podcast as a media partner to enable a constructive dialog with senior living leaders to fight social isolation and collaborate with activity and life enrichment professionals. This will enable the industry to deliver resident engagement that staff want and residents deserve.

Charles de Vilmorin, CEO and Co-founder of Linked Senior, shared that, “The #ActivitiesStrong initiative was born out of the need to acknowledge, educate and empower activity and life enrichment directors. It is now critical to invite senior living executives and thought leadership to the conversation and I couldn’t think of a better partner than Bridge The Gap™ Podcast: their platform is professional, far reaching and they share common values and a deep desire to disrupt our industry towards the goal of advancing quality of life for older adults.”

The partnership will include thought leadership, such as executive focused webinars and roundtables, conversations on the future of resident engagement and innovative approaches to furthering resident quality of life. The educational programming will kick off on Tuesday, December 15th, 2020 at 1pm EST with a webinar featuring Sara Kyle, PhD, Founder and Principal LE3 Solutions and Kelly Stranburg, M.Ed, Principal, LE3 Solutions. Attendees will learn how providers can ensure that their engagement programs are aligned with resident needs and desires.

Bridge The Gap™ Podcast founders and co-hosts Josh Crisp and Lucas McCurdy are honored to be a media partner of #ActivitiesStrong and will use the podcast network platform to inform, educate and influence the senior living industry on this specific need to empower activity and life enrichment directors.

“We close nearly every episode by reminding healthcare workers that they are important, loved and appreciated,” McCurdy said. “Teaming up with #ActivitiesStrong is one tangible way we can show that to the great people in our industry.”

“The team members in the communities are who brings life to residents day in and day out,” Crisp said. “We are honored to support and partner with #ActivitiesStrong to help shed light on the resources and engagement needed for the vital activities and life enrichment directors.”

Linked Senior is an evidence-based resident engagement platform for senior living. The platform optimizes the person-centered experience for residents by empowering staff with digital tools to assess, plan, implement and evaluate engagement for the entire resident population.

The mission of Bridge The Gap™ podcast is to inform, educate and influence the senior housing industry by providing thought leadership and discussion surrounding the most pressing issues in senior care.

Share article on social media or email:

RiskStream Collaborative Completes Proof of Concept for Mortality Monitor™ Application With Broad Potential


“With the outbreak of Covid-19, the timely closure of life and annuity claims has never been more important and remains a challenge. Mortality Monitor will make inefficient manual processes obsolete by sharing decedent information securely, in real-time, and with transparency and traceability.”

In collaboration with Nationwide, Prudential Financial, and Securian Financial,The Institutes RiskStream Collaborative™, the risk management and insurance industry’s largest enterprise-level blockchain consortium, has announced proof-of-concept completion of the Mortality Monitor application, which will help carriers close out and process death benefits and claims more efficiently.

Providing a single source for decedent information and allowing the secure and permission-based exchange of this data among RiskStream Collaborative member companies, Mortality Monitor sets the stage for a large-scale decentralized death registry. The RiskStream Collaborative partnered with Kaleido to leverage their blockchain services and develop the application, which serves as RiskStream’s first life and annuity-based distributed ledger proof-of-concept.

“We are living through unprecedented times with the outbreak of COVID-19. Timely closure of life insurance and annuity claims has never been more important and remains an ongoing challenge, as verification and validation of death claims requires carriers to have comprehensive decedent information, but no one source has emerged to fill this need,” said Christopher McDaniel, president of the RiskStream Collaborative. “The Mortality Monitor solution makes inefficient manual processes obsolete by sharing decedent information securely, in real-time, and with transparency and traceability.”

The proof-of-concept efforts emphasized Mortality Monitor’s ability to securely share death data amongst the network of participants. It represents the first project to advance through RiskStream Labs, a framework established by the RiskStream Collaborative that’s focused on accelerating completion of blockchain-centered innovations through participation from both member and nonmember organizations. The application gained initial support from Nationwide, Prudential, and Securian Financial—member organizations of the RiskStream Collaborative that participated in the proof-of-concept endeavor.

“The Mortality Monitor proof-of-concept shortens the response time from date of death to notification of beneficiary, thus improving the beneficiary’s experience while reducing time, cost, and risk to the insurer,” said Eric Henderson, President of Nationwide Annuity and chair of the Life & Annuity Advisory Board. “Nationwide is committed to driving digital innovation and is pleased to be part of this important work to help shape the future of claims processing for the life and annuity industries.”

“This proof of concept is a prime example of how we are leading through technology innovation, and for Prudential, it is all about protecting the safety, security, and privacy for our customers during what can be a particularly challenging time. We are a socially responsible organization and believe it’s important to protect our customers. We are excited that our participation in the consortium allows us to invest in solutions that solve real-life challenges in our industry,” said Bob Bastian, CIO Global Technology, Individual Solutions Group at Prudential and Vice Chair of the Life & Annuity Advisory Board. “The Mortality Monitor use case illustrates how blockchain can be applied to enhance customer-centricity and drive innovation.”

“This progress is exciting to see and only a starting point for the innovation this consortium will bring to the industry. We see a great opportunity to build a “single source of truth” in the industry using blockchain technology to better serve our customers and their loved ones while protecting their personal data. Prudential is proud to be a founding member of the consortium and to partner together with innovative leaders to provide new solutions that are secure and lead to better outcomes for our customers,” said Anindya Sengupta, Vice President, Business Development, Emerging Technology Solutions at Prudential.

“Customers entrust life insurers to care for their loved ones if something happens,” said Brian Oberman, Innovation Lab Director at Securian Financial. “Often times, a death benefit claim is the first experience loved ones have with a life insurer. The Mortality Monitor™ application helps us support our commitment to provide an excellent customer experience at a time of grief. We’re proud to be a member of the RiskStream Collaborative.”

The RiskStream Collaborative operates in property casualty, reinsurance and life & annuities. Its life & annuities (L&A) sector was born in collaboration with LIMRA, a research and professional development trade association for the financial services industry, which continues to serve in an advisory capacity to the L&A consortium. RiskStream aims to expand its network of members and connect insurance-oriented organizations to create greater efficiencies and achieve growth opportunities through blockchain innovations. The focus for Q4 2020 is to conduct a viability study to analyze and quantify the overlap of claims across carriers for the Life, Annuity, and Retirement sectors.

“The Mortality Monitor™ application demonstrates industry-leading innovative technology that optimizes the claims process. This allows carriers to proactively service beneficiaries and ensure a seamless, and stress-free experience,” said Patrick Schmid, vice president of the RiskStream Collaborative. “Carriers that wish to gain access to the Mortality Monitor™ application, expand their technical knowledge, and collaborate with leading carriers can still join the Mortality Monitor Working Group in RiskStream Labs through the end of the year.”

###

About The Institutes RiskStream Collaborative

The Institutes RiskStream Collaborative™ is the risk management and insurance industry’s first enterprise-level blockchain consortium that brings together experts and developers to advance insurance-specific use cases via Canopy, a custom blockchain architecture. The RiskStream Collaborative is committed to equipping organizations to work together to inspire product innovation, enable efficiencies, and open new technological frontiers.

The Institutes, the leading provider of risk management and insurance knowledge education and solutions, offer professional designations, including the CPCU® program. In addition, The Institutes provide introductory, foundational, and leadership courses and programs; online and continuing education courses; custom solutions; events and conferences; online and print news platforms; assessment tools; and research reports.

CPCU is a registered trademark of The Institutes. All rights reserved.

About Kaleido

Kaleido is a digital transformation platform that offers blockchain-as-a-service, digital assets services, smart contract management, network governance, insights and monitoring, collaboration services, apps and integration, along with a marketplace with third-party integrations, developer tools, and connectors.

Kaleido has been running thousands of networks globally with built-in high availability, disaster recovery, and 99.99% uptime achieved over the last three years. Kaleido provides multi-party consortia with one native network across the major public clouds, across all global regions and on-premise deployments. It offers the industry’s highest levels of security, compliance, performance, and scalability, along with enterprise SLAs and 24/7 support. It is the first blockchain SaaS to have achieved ISO 27K certification.

The leading global enterprise blockchain consortia in production today across trade finance, supply chain, payments, insurance, banking, healthcare, media and entertainment, and retail rely on Kaleido for continued innovation across the open-source and blockchain communities.

To learn more, visit us at kaleido.io

While Hospital Margins Shrink, Leaders Search for More Sustainable Operating Models – Industry Analysis by Loyale Healthcare


Patient expectations of healthcare providers have been transformed by the COVID-19 crisis.

To truly realize the considerable promise of virtual health over the long-term, health systems and hospitals must employ digital tools to reduce or remove the financial barriers to patient care and payment. – Kevin Fleming, CEO, Loyale Healthcare

Healthcare consulting firm KaufmanHall just published its November flash report with updated financial analyses of hospitals and health systems. For the period Jan. 1 through Oct. 30, 2020 median changes across the U.S. reflect “a challenging month for hospitals and health systems nationwide amid ongoing instability spurred by the COVID-19 pandemic.” Not surprisingly, operating performance remained below 2019, managing only 2.4% on the Kaufman Hall Operating Margin Index with CARES Act funding and negative 1.6% without CARES.

Throughout this challenging year, healthcare has been hit with higher expenses (up 14% per Adjusted Discharge YTD) and reduced volumes (down 11%). Pointing out that “Expenses continued to rise as hospitals replenished staffing levels in light of rising COVID cases and incurred the cost of drugs, personal protective equipment and other supplies needed to ensure safe care,” the report goes on to predict that, “such increases will put hospitals in a tenuous situation if volumes plummet,” something that now appears increasingly likely as COVID cases and hospitalizations continue to spike and states impose ever stricter stay-at-home policies.

It’s tempting to view healthcare’s disappointing financial performance so far in 2020 as an anomaly – something that will quickly self-correct when the crisis is over and market conditions get back to normal. Based on our clients’ experiences, however, we’re convinced that patients won’t be satisfied returning to healthcare’s old normal. If health systems and hospitals hope to benefit financially from the surge in demand that will follow the pandemic, they’ll need to recognize and adapt to some important consumer dynamics that predated the pandemic but have been amplified because of it.

Better Patient Care. Lower Costs. Higher Margins – Realizing the Benefits of Holistic Virtual Care

The COVID-19 crisis has taught Americans that it is not necessary to go to a medical facility to get care from a qualified health professional. Before the pandemic, virtual care was a minor sideline for most healthcare providers with little or no long-term value as a strategic asset. But with support from the Center for Medicare and Medicaid Services (CMS) during the national emergency, virtual care delivery quickly became one of the most impactful silver linings during the crisis.

The success of the channel for safer, more cost-effective care delivery caused CMS administrator Seema Verma to announce as recently as October that, “CMS is taking action to increase telehealth adoption across the country.” She went on to state that, “This revolutionary method of improving access to care is transforming healthcare delivery in America. (We) will not let the genie go back in the bottle.”

At the same time patient acceptance of – and demand for – telehealth has exploded, hospitals and other healthcare providers have discovered compelling financial benefits to the improved productivity, reach and scalability of digitally delivered care. But the benefit potential for providers is limited by the fact that telehealth as it is currently imagined has a number of inherent long-term deficiencies.

As stunningly successful as telehealth has proven to be during the pandemic, it’s important to note that virtual care as it is currently delivered is effectively incomplete. And even though Medicare reimbursements for expanded telehealth services continue to encourage Americans to access their healthcare electronically, the patient benefits of telehealth are exclusively clinical. In other words, they impact the patient’s medical experience only. That would be fine if patient care experiences were composed entirely of medical needs and events, but we all know that the actual care journey is much longer and more complex. And nowhere is that journey more fraught with obstacles than with patients’ financial experiences.

Even before the pandemic, millions of Americans were delaying or avoiding care because of concerns about their ability to afford the personal out-of-pocket costs for deductibles and copays. Since the pandemic began, according to research published by Kaiser Health News, “48% of Americans said they or a family member has skipped or delayed medical care because of the pandemic, and 11% of them said the person’s condition worsened as a result…” The same report found that, “about 3 in 10 adults have had trouble paying for food and 11% paying medical bills. Nearly 1 in 4 adults said they or a family member in the next year will likely turn to Medicaid.”

We have written extensively on this topic in recent months. In “Patients Love Virtual Health. Digital Financial Engagement Makes It Better,” we shared the results of consumer research published this fall. Noting that, “patients are very happy with their COVID-19-inspired virtual care experiences,” but that, “To achieve a truly patient centric experience, Hospitals and Health Systems must expand their vision for virtual care to include every patient experience in every setting.” As noted above, this is particularly true when it comes to the patient’s financial experience.

In the same article, we explored the convergence of digital patient enablement and consumerism. Citing a report published by IBM titled “Patient-centric healthcare: It’s time for a new operating model,” we expanded on the report’s observation that, “Success comes when a company learns to deliver experiences or content in a personalized, participatory way, designed with the consumer’s preferences in mind,” with our own experiences working with some of the country’s largest healthcare providers.

Concluding that “COVID-19-inspired innovation and patient enthusiasm for digital engagement have created the ideal environment for the rapid development of holistic, patient-centered operating models,” we shared our clients’ determination to, “reframe their vision of care to include every dimension of the patient experience.” Pointing out that, “Consumers are demanding it. The competition is stepping up to deliver it, and the technology exists to realize it,” we concluded that, “healthcare providers who expect to thrive in the post-COVID-19 healthcare marketplace must embrace it.”

Ramping Up for Healthcare’s Post COVID-19 Recovery

Like it or not, the pandemic has forced a historic reset on the American healthcare industry. It’s impossible to predict with certainty what the industry will look like in the next few years, but it is possible to imagine the opportunities. In analysis published by PwC titled, “COVID-19 recovery for the healthcare ecosystem, gearing up for the next normal,” the consulting firm offers a planning framework to, “rethink the enterprise and accelerate transformation to seed future growth.” We agree completely, especially as the potential transformation affects consumers’ financial experiences, our area of expertise for thirty years.

To truly realize the considerable promise of virtual health over the long-term, health systems and hospitals must employ digital tools to reduce or remove the financial barriers to patient care and payment. Even before the pandemic, patient payments were an increasingly important revenue source for providers everywhere. By delivering financial transparency, affordability options, and clear & concise personal communications, we’re seeing every day how patients’ financial experiences can be elevated to the level of their clinical experiences.

As providers look for new, more cost-effective operating models to meet the high standards of what PwC calls the New Health Economy, our clients’ experiences are proving that holistic virtual care can be leveraged to reduce costs, improve patient engagement and drive growth all at the same time. As the industry looks for certainties in the uncharted territory after the pandemic, better patient financial experiences look like a sure bet. That’s a race we’re happy to be running in.

Kevin Fleming is the CEO of Loyale Healthcare

About Loyale

Loyale Patient Financial Manager™ is a comprehensive patient financial engagement technology platform leveraging a suite of configurable solution components including predictive analytics, intelligent workflows, multiple patient financing vehicles, communications, payments, digital front doors and other key capabilities.

Loyale Healthcare is committed to a mission of turning patient responsibility into lasting loyalty for its healthcare provider customers. Based in Lafayette, California, Loyale and its leadership team bring 27 years of expertise delivering leading financial engagement solutions for complex business environments. Loyale currently serves approximately 12,000 healthcare providers across 48 states. Loyale is proud to have an enterprise-level strategic partnership with Parallon which includes the deployment of Loyale’s industry leading technology at all HCA hospitals and Physician Groups.

Patterson Veterinary Announces Partnership with Roya.com


News Image

We’re excited to help Patterson customers create an online experience that is unique to their individual practices and provide an effective conversion funnel driven by real-time data and the ever changing user behavior.

Patterson Veterinary today announced an exclusive partnership with Roya.com to offer corporate consolidators and multi-location customers the ability to digitally brand their practices through the latest website technology and marketing tools.

Roya.com is a leading provider of digital marketing and CMS platforms, specializing in custom web design and digital marketing services. Through this agreement, Patterson Veterinary customers will now be able to utilize Roya.com’s CANVAS® platform and Marketing Packages at special partnership pricing.

“Now more than ever, it is so important that we help customers not only serve their patients, but also generate leads to continue growing their businesses,” said Dan Holland, Director of Technology, Patterson Veterinary. “Partnering with Roya.com will especially help our larger, multi-location practices by offering tailored services designed to help them brand their practices and effectively track all efforts.”

Additionally, Roya.com says the decision to partner with Patterson was an easy one, based on the two companies’ shared commitment to their customers.

“Roya.com focuses on understanding the individual needs of our customers, while keeping a close eye on industry trends and best practices,” said Mo Ranji, Founder and CEO of Roya.com. “We’re excited to help Patterson customers create an online experience that is unique to their individual practices and provide an effective conversion funnel driven by real-time data and the ever changing user behavior.”

For Patterson, this partnership supports Patterson Veterinary’s key objective of providing the best, most relevant and most innovative technology solutions to veterinarian practices.

“Finding the right partners that bring value to our customers is a top priority for our organization,” adds Holland. “Patterson Veterinary is dedicated to providing the most innovative technology solutions to veterinarian’s practices, and this partnership with Roya.com allows us to continue supporting that goal.”

To learn more, contact your Patterson Veterinary sales representative for a demo.

About Patterson Veterinary

Patterson Veterinary, combined with sister company Animal Health International, forms one of the largest animal health companies in North America, distributing products, equipment, technologies and practice-management solutions to companion animal veterinary clinics, livestock operations and dealer/farm stores. For more information, visit pattersonvet.com and http://www.animalhealthinternational.com.

About the Canvas® CMS Platform

Roya.com’s Canvas® CMS is a best in class technology with a range of built-in features to market small to midsize businesses online. The proprietary platform is powered by cutting edge cloud based technologies and is designed to elevate online marketing initiatives and ultimately convert online visitors to customers. As an early adaptor to Google’s AMP project, Roya.com continues to differentiate its offerings, marketing services and CMS products as best in class.

About Roya.com

Roya.com is a SaaS provider of Canvas CMS Platform digital marketing & CMS platforms for thousands of Veterinary Practices across the United States and Canada. Roya.com is one of the fastest growing companies in San Diego, California. For more information visit Roya.com’s Blog or call 858-345-5500.

Share article on social media or email:

Inference Analytics Neural-network (IANN) Auto-Impression Assistant Now Available on the Nuance® AI Marketplace


IANN is a next-gen text-based AI platform geared towards improving physician productivity and reducing errors in care delivery.

Inference Analytics Inc., a Chicago-based healthcare Artificial Intelligence startup, today announced Beta availability of its Auto-Impression Assistant software on the Nuance® AI Marketplace. The Auto-Impression Assistant is the first radiology solution to be launched by Inference Analytics and relies on the Inference Analytics Neural Network platform (IANN). IANN is a next-gen text-based AI platform geared towards improving physician productivity and reducing errors in care delivery. The Nuance AI Marketplace is the first and largest portal with one-stop access to a wide range of AI diagnostic models from within the industry’s most widely used radiology reporting platform.

The Inference Analytics Neural Network (IANN) Auto-Impression Assistant is the first non-pixel-based AI solution (i.e., an AI solution that uses AI to process text as opposed to images), available on the Nuance AI Marketplace and offers seamless real-time integration with Nuance’s PowerScribe One platform. IANN is based on a text-based AI system that was trained by leveraging several million radiology reports from a premier academic hospital. Initial results were presented at 2019 RSNA.

Through deep learning methodologies designed to understand healthcare text and language, IANN augments and complements the roles played by physicians. The platform generates impressions based on a radiologist’s findings and the patient’s clinical history.

“We are mimicking how the human brain understands language. IANN’s deep learning-based Natural Language Processing (NLP) identifies information from text and narratives using patterns similar to the human brain,” said Inference Analytics Founder and CEO Farrukh Khan. “IANN replicates an experienced physician’s ability to translate notes and reports into clinically meaningful conclusions and suggestions. The IANN Auto-Impression Assistant serves as a radiologist’s assistant. Since radiologists can be expected to read and document more than one hundred cases in a single day, any technology that can help reduce the chances of burnout, fatigue and errors can have an enormous impact. Over the next few months we will have leading radiologists participate in Beta testing the Auto-impression Assistant, preparing the platform for general availability in early 2021.”

“One of the core deficiencies in healthcare IT systems is the ability to understand and process unstructured healthcare data such as text, and traditional Natural Language Processing (NLP) rules-based technologies have not shown good results, creating the need for an NLP Platform like Inference Analytics, a system that is using next-generation techniques to understand text and the copious amounts of notes and narratives that physicians are creating. The IANN Auto-Impression Assistant is an example of what is possible with next generation NLP technology and how it can impact a radiologist’s workflow.” said Dr. Paul Chang, MD, Professor of Radiology, Vice Chair, Radiology Informatics, UChicago Medicine.

Nuance AI Marketplace

The Nuance AI Marketplace functions like an app store dedicated to radiology. It gives AI developers consolidated, at-scale access to users of the Nuance PowerScribe™ One platform, the radiology reporting system trusted by approximately 80 percent of U.S. radiologists across more than 8,000 connected healthcare facilities. Radiologists can discover, test, and use AI services from within their familiar PowerScribe reporting and workflow orchestration solutions to increase reporting efficiency and quality, and to help care teams improve patient outcomes and reduce healthcare costs.

A built-in feedback channel lets users share real-world results with developers for algorithm refinement and post-market surveillance. Hospital systems benefit with simplified purchasing and metrics showing AI usage, costs, and performance. The Nuance AI Marketplace has made it easy for partners like Inference Analytics to build and distribute AI services in an integrated and seamless manner. The AI Marketplace creates a win-win for partners like Inference Analytics and Nuance.    

ABOUT INFERENCE ANALYTICS

Inference Analytics is developing a neural network-based AI platform called IANN (Inference Analytics Neural Network) to reduce healthcare inefficiencies and physician burnout while simultaneously improving the overall quality of care. We are piloting IANN at leading academic hospital systems, and we enjoy a strong strategic partnership with Nuance, one of the leading companies providing radiology solutions globally to radiologists. IANN is capable of understanding and applying medical language across multiple clinical specialties and domains. To learn more about IANN and how to become a Beta user, visit the Inference Analytics website.

Share article on social media or email:

Germinator Mobile Sanitizing and Disinfecting Adds ATP Monitoring to its Service Offerings


Photo of Germinator's ATP Monitoring Device

Germinator offers ATP testing before and after its sanitizing and disinfecting service to ensure they have achieved an optimal hygiene level.

Our mission is to serve as long-term partners for our customers to help them live protected, said Jeff Gill, CEO of Germinator.

Germinator Mobile Sanitizing and Disinfecting continues to dominate the sanitization and disinfection industry, announcing the addition of adenosine triphosphate (ATP) monitoring to its service offerings as part of its patent-pending methodology. ATP monitoring allows Germinator to test surfaces for the potential presence of living microorganisms in as little as 15 seconds prior to sanitizing and disinfecting.

ATP is an energy molecule found in all living organisms —including bacteria, mold and other potentially harmful microorganisms. When activated, ATP gives off a bright bioluminescent light, which is measured in relative light units (RLUs). Upon entering a business or residence, Germinator will take samples from surfaces using swabs, which are then inserted into the luminometer. The luminometer gives a rapid and accurate reading of ATP on a surface. The higher the light output, the greater the indication of the need for proper cleaning.

“We are excited to implement the ATP monitoring technology into our sanitizing and disinfecting process,” said Jeff Gill, CEO of Germinator. “Our mission is to serve as long-term partners for our customers to help them live protected. We plan to be there every step of the way to ensure that we properly sanitize and disinfect areas of concern and measure the effectiveness of our work after a job is complete.”

Germinator will offer ATP monitoring prior to performing its sanitizing and disinfecting process. Once the initial ATP test has been completed, Germinator applies its Genesis surface treatment. Genesis is a one-step cleaner and broad-spectrum sanitizer and disinfectant treatment that harnesses the power of hypochlorous acid (HOCI). Derived from naturally occurring minerals, Genesis not only eliminates odors at their source, but kills a wide range of bacteria including Staphylococcus aureus, MRSA, Salmonella enterica and Pseudomonas aeruginosa, and viruses including norovirus, rotavirus and adenovirus on hard, non-porous, environmental surfaces. It meets the Association of Official Agricultural Chemists (AOAC) germicidal spray standards for Hospital Grade Disinfection and is on the EPA N List of products determined to meet the criteria for use against SARS-CoV-2, the virus that causes COVID-19. As a result, this treatment will eliminate bacteria and viruses that may reside in your environment without the use of harsh chemicals or fumes.

Once Genesis has been applied, Germinator applies its Shield, a water-based quaternary ammonium compound that imparts a durable bacteriostatic finish. It is EPA-registered as effective against mold, mildew, algae and odor-causing bacteria. This application creates an invisible barrier that combats deterioration and discoloration and promotes freshness for up to three months.

The Genesis and Shield products are applied by using an electrostatic sprayer, which is the most efficient and effective means of delivering the products to the intended application sites. After Germinator’s surface treatment and protectant services are applied, the company’s highly trained field specialists retest ATP levels to ensure the surfaces have achieved the intended results.

Upholding the highest standards of sanitizing and disinfecting, Germinator makes claims that are scientifically supported and within EPA regulations. Germinator’s research and process are validated by the Germinator Scientific Advisory Board. The board is made up of key leaders such as Dr. Roscoe M. Moore, Jr. —who was an Assistant to the United States Surgeon General for five administrations; Dr. Harold Smith, who has extensive expertise in cell biology, molecular biology and biochemistry, along with decades of experience leading sponsored research on infectious diseases for the National Institutes of Health (NIH); Dr. David Miller, the Protocol Chair of University of Rochester Center for AIDS Research Community Advisory Board; and Chad S. Johnson, Esq., a Harvard-trained corporate, legislative, and regulatory attorney with significant experience in advising health and biotechnology companies.

Germinator was founded by Jeff Gill in 2015 with the vision of providing an effective method of proper sanitizing and disinfecting for businesses and households. Since February, Germinator has continued to rapidly expand across the country.

With Germinator, society can now have greater peace of mind and the freedom to live or work in a sanitized and disinfected environment. For more information, visit http://www.thegerminator.com.

Share article on social media or email:

FDA grants AlloMek Orphan Designation for CIP-137401, Treatment of Neurofibromatosis Type 1


News Image

AlloMek Therapeutics, a privately held orphan disease-focused company, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan-drug designation for its macrocyclic MEK kinase inhibitor, CIP-137401, for the treatment of Neurofibromatosis type 1 (NF1).

The FDA awards “orphan” status for treatments of diseases affecting fewer than 200,000 people in the U.S., for drugs to be used for the safe and effective treatment of rare diseases or for drugs that are not expected to recoup the costs of development and marketing. This designation qualifies AlloMek for incentives including certain tax credits and a new drug application fee waiver. It also entitles AlloMek to a period of market exclusivity after approval.

According to the Children’s Tumor Foundation, Neurofibromatosis-1 is one of the most common inherited neurological disorders, affecting about 1-in-3,000 people throughout the world.

AlloMek’s lead drug, CIP-137401, is a macrocyclic MEK kinase inhibitor with excellent pharmacokinetics and a profile optimized for potency and safety. The drug has been tested in an established preclinical model of NF1 and been found to dramatically reduce both absolute tumor numbers and the size of plexiform neurofibromas. The potential to administer this drug on a once-daily basis makes it an excellent candidate to combine with therapeutics with complementary mechanisms of action.

CIP-137401 has been shown in IND-enabling animal toxicological studies to be well tolerated with limited side effects which could potentially result in an improved therapeutic index (TI) and best-in-class profile. AlloMek is currently focused on developing the compound in rare diseases, including LMNA cardiomyopathy and Noonan Syndrome, along with NF1. The company is also seeking partnerships for trials in oncology, both as a single agent and in combinations.

The company plans to begin human testing in 2021.

About AlloMek:

AlloMek Therapeutics is a Woodbridge, CT based, privately held orphan disease-focused company, developing therapeutics using macrocycles. AlloMek is applying its expertise in macrocyclic chemistry and molecular modeling to design novel drug candidates to build a high-quality pipeline of drug candidates. For more information, please visit https://allomek.com.

Forward-Looking Statements

This press release contains forward-looking statements, including statements regarding potential benefits associated with CIP-137401 and Orphan Drug designation. These statements involve known and unknown risks, uncertainties and other factors which may cause any actual benefits to be materially different from those expressed or implied by the forward-looking statements. These statements reflect our current views and are subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Some of the factors that could affect the forward-looking statements contained herein include: Orphan Drug and Fast Track designations by the FDA may not lead to a faster development, regulatory review, or approval process with the FDA and does not increase the likelihood that CIP-137401 will receive marketing approval; and ongoing and future preclinical and clinical development of CIP-137401 may not have positive results.

Share article on social media or email:

Green Goo Partners with PARSA to Develop Sustainable Herb Garden Initiative in Afghanistan


PARSA (Physiotherapy and Rehabilitation Support for Afghanistan)

The Green Goo Partnership creates a program where Afghan women can support themselves and their children through a cottage industry and products that can be made at home.

All-natural body care brand Green Goo, under parent company Sierra Sage Herbs, recently established a partnership with PARSA (Physiotherapy and Rehabilitation Support for Afghanistan) to develop a sustainable herb garden program to foster vocational training and economic opportunities for members of PARSA’s Healthy Afghan Women’s Support Groups as part of its Trade Afghan Business Network.

In tandem with PARSA’s professional staff, Green Goo will provide counsel, resources, and training to support group members, who will then grow a selection of herbs that may be used to produce clean, natural body care products. The products, which will be formulated by Green Goo Co-Founder and Director of Product Development Jen Scott to fit the Afghan context, will be simple to produce and will only require locally-available resources. Suggested starter products include healing first aid, dry skin, and pain relief salves. The PARSA support-group members will be trained in growing, dry processing, and storing the herbs, in addition to learning to produce and package the respective products. They will then be taught basic entrepreneurship, wherein the women will be able to sell the products locally, reinvest their earnings to grow their small businesses, and earn income for their families. PARSA intends to start the program as a pilot with a support group based at their head offices in Marastoon, Kabul.

“The idea of introducing a sustainable herb garden model to communities, especially women, in developing nations has been a concept we have evolved for the better part of the last decade,” said Green Goo Co-Founder and CEO Jodi Scott. “We feel so incredibly fortunate to have found a partner in PARSA who can help us make this dream a reality. We’ve seen the extraordinary healing qualities of herbs in our own products firsthand, and to be able to share that insight and ingenuity with PARSA beneficiaries, and to empower them to take these ideas to create economic opportunity for their families, is especially momentous.”

As part of the Green Goo partnership with PARSA, Jodi Scott has been named to the philanthropic organization’s international Board of Directors, where she will also serve as an adviser to their Trade Afghan Business Network, a mentorship program established in 2013 in response to women in Afghan communities who requested help developing and finding markets for their products.

“The Green Goo Partnership creates a program where Afghan women can support themselves and their children through a cottage industry and products that can be made at home,” noted PARSA Executive Director Marnie Gustavson. “This is especially important in the current historical context in Afghanistan where women’s rights to economic access is becoming more and more uncertain because of the re-incursion of the Taliban in Afghan communities, and the subsequent increase in violence against women. This project will provide a safe network for women entrepreneurs to earn a living, to survive the instability of the current political conflicts, and to continue to have a voice in their future.”

Green Goo plans to make an annual financial contribution to PARSA in support of the herb garden initiative and various other programs. For the month of December 2020, Green Goo will also donate a percentage of their hand sanitizer sales to the organization.

###

Media Contact:

Shea Martin, Vice President of Public Relations

shea@greengoohelps.com

T: 917-903-2795

http://www.greengoo.com

Facebook/Instagram/Twitter — @greengoohelps

#PlantsWithPurpose #SpreadGoodness

About Green Goo

Formed in 2008, Green Goo is a women-owned, family-operated, B-Corp. Our products are cruelty free and made in the USA with 100% natural ingredients. We started small, making products for friends, family, and the local farmer’s market, and we have now grown into a thriving, value-driven company. As we evolve, we remain committed to our roots: a time-honored infusion process, high-quality ingredients, and simple, effective products that are safe for you, your family, and the environment. Visit Green Goo to learn more.

About PARSA

PARSA, an international 501(c)(3) nonprofit organization, trains and develops professional Afghan leaders who care for the women, youth, impoverished families, and the disabled citizens of Afghanistan by offering innovative programs that provide the greatest impact to these communities. They believe strongly in empowering visionaries who want to make a positive change and their organic approach has allowed them to be highly creative in program development. PARSA has been working at the most grassroots level in Afghan communities since 1996, consistently evolving over the years to meet the changing needs of the people they support. Visit PARSA to learn more.

Share article on social media or email:

Kognito and Togetherall Partner to Extend their Support of Campus Mental Health


Kognito, a leading health simulation company offering skill-building simulations that promote safe and healthy campuses, has partnered with Togetherall, a 24/7 online peer-to-peer mental health community.

Through this new partnership, Togetherall and Kognito will help campuses expand their mental health services to students—particularly remote options, which have become increasingly important during the pandemic. Combining Kognito’s practice-based learning experiences with Togetherall’s online community will help colleges build a stronger peer-to-peer support system in their efforts to enhance the safety and wellbeing of their campus community.

Togetherall is an online peer-to-peer mental health community where students can anonymously seek and provide support 24/7. It is moderated by registered practitioners who keep members safe and facilitate the process. Togetherall provides service to more than 200 post-secondary institutions serving 1.6 million students worldwide, with thousands of new members joining each month.

Kognito offers a suite of evidence-based virtual human simulations for both students and faculty, used by over 700 campuses to address critical issues including mental health, suicide prevention, and sexual misconduct prevention. A key component of its student-focused online simulations is allowing students to practice conversations with peers. Students learn how to identify and talk to friends in distress in an experiential private practice environment with virtual humans, building the skills and confidence to have these conversations in real life.

This partnership comes at a time when colleges around the country are responding to the growing mental health needs of students—almost 75% of college students say their mental health has worsened during the pandemic. Engaging students to support each other is one important strategy to foster a more positive campus climate. Kognito’s solutions go beyond awareness to help grow student skills, while Togetherall provides students with a place to use those skills and support one another.

“Partnering with Togetherall will allow Kognito to expand how we support the hundreds of schools that already utilize our comprehensive mental health and resilience skill-building simulation products,” says Ron Goldman, Co-Founder and Chief Simulation Strategist at Kognito. “As more schools adopt a stepped care model, they can continue to look to Kognito as part of a comprehensive solution to improve student mental health and wellness.”

Offering a spectrum of mental health support resources aligned with a stepped care model is becoming more common for campuses. But with the shift to remote learning, the need to think outside the “one-on-one counseling” box has grown even more. As campuses seek solutions to address their students’ mental health needs, Togetherall and Kognito work in concert to help fulfill a need at a critical time.

“Students need mental health support perhaps now more than ever, which can be a challenge during this pandemic when campus services are often limited due to safety concerns,” says Matthew McEvoy, Senior Vice President and General Manager of Togetherall in North America. “We’re excited to partner with Kognito to provide a more comprehensive solution to higher education institutions and help them give more support avenues to their student community.”

About Togetherall:

Established in 2007 as Big White Wall, Togetherall is a leading online mental health service that provides millions of people throughout the UK, New Zealand, Canada and the US access to community and professional support, 24 hours a day, 365 days a year. The service is registered with the Care Quality Commission (CQC) and is clinically proven to help those who are struggling with stress, isolation, anxiety, depression and other common mental health issues. Togetherall has supported over 220,000 members with their mental health since launch in partnership with clients in the corporate, education, health and charity sectors, and all serving military personnel and veterans in the UK. Learn more at http://www.togetherall.com.

About Kognito

Founded in 2003, Kognito is a leader in designing immersive practice experiences that develop and assess users’ competencies in transforming challenging health conversations into opportunities to drive meaningful and sustainable changes in attitudes, self-efficacy, and behavior. Kognito’s award-winning online and mobile experiences use emotionally responsive virtual humans to simulate real-life conversations within a risk-free and adaptive environment that provides personalized feedback and in-depth analytics. Kognito uses a science-driven, research-proven approach and currently has more than 450 clients in education, government, and healthcare settings. Learn more and access demos at http://www.kognito.com.

Share article on social media or email: